One issue has come to divide the state’s legal cannabis industry in recent months: Aspergillus testing. Analytical Cannabis reached out to key figures on both side of the debate to find out why fungi testing has become so fraught.
The researchers say their findings add to the growing body of evidence that psilocybin can be used in a clinical setting to treat depression.
Cannabis consumers have higher levels of cadmium and lead in their blood than people who don’t consume the drug, according to a new study.
A significant minority of medical cannabis patients go on to develop cannabis use disorder (CUD), according to a new study. This proportion, however, is still lower than the proportion of recreational consumers with CUD.
Cannabis products in Oregon no longer have to be tested for Aspergillus fungi following a suspension order from the Oregon Court of Appeals.
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold was found in a batch of cannabis flower.
Heavy metals expert Robert Thomas previews his new book, the 4th Edition of Practical Guide to ICP-MS and Other Atomic Spectroscopy Techniques: A Tutorial for Beginners.
Cannabis and hallucinogens are more popular than ever in the US, according to an ongoing National Institutes of Health (NIH) survey.